Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
586,197
-
Share change
-
+586,197
-
Total reported value
-
$3,220,392
-
Price per share
-
$5.43
-
Number of holders
-
18
-
Value change
-
+$3,220,392
-
Number of buys
-
18
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2018
As of 30 Jun 2018,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
586,197 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, COMERICA BANK, ROYAL BANK OF CANADA, Federation des caisses Desjardins du Quebec, BANK OF MONTREAL /CAN/, UBS Group AG, DEUTSCHE BANK AG\, BANK OF AMERICA CORP /DE/, and CITIGROUP INC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.